Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

GERN vs ASTM: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

GERN Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 7–3 Matrix Metrics)

GERN Overall Winner 6-Pillar Tally: GERN 5 – 1 ASTM Matrix Metrics: GERN 7 – 3 ASTM

As of Nov 20, 2026, Geron Corp (GERN) is the stronger overall head-to-head candidate over ASTM (ASTM) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). GERN carries a Unified Composite Score of 48.4/100 (HOLD) at $0.87 (49.5x Forward P/E, -7.2% operating margin), whereas ASTM carries 50.6/100 (HOLD) at $25.29 (N/M Forward P/E, N/A operating margin).

  • Composite vs. Pillar Nuance: While ASTM currently prints a higher short-term Unified Composite Score (50.6/100 HOLD vs. GERN 48.4/100 HOLD), GERN captures the overall institutional head-to-head verdict (7–3 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (-7.2% vs. N/A operating margin) and revenue trajectory (+27.4% vs. N/A YoY).
  • Technical & Structure Timing Caution: GERN is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 35.3); meanwhile ASTM trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI N/A). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About GERN vs ASTM
GERN NASDAQ Head-to-Head Winner
Geron Corp
Pharmaceutical Preparations
$0.87
-4.63% 1D
Market Cap $588.2M
TTM Revenue $218M
Forward P/E 49.5x
Beta / 30D Vol 1.48β · 102% Vol
Unified Composite Score
48.4 / 100 HOLD
Tech 40.0 Fund 56.0 Flow 65.0 Mom 64.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -15.6%), weak momentum, RSI 35
RSI-14: 35.3 · SMA20: $0.98 · SMA50: $1.13
ASTM US Equity
ASTM
Institutional Equity
$25.29
+0.08% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol N/A
Unified Composite Score
50.6 / 100 HOLD
Tech 50.0 Fund 50.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Trend telemetry aligned with daily close.
RSI-14: N/A · SMA20: N/A · SMA50: N/A

6-Pillar Scorecard Institutional Category Breakdown (GERN 5 – 1 ASTM)

Columns: Metric · GERN · ASTM
1. Valuation Multiples GERN
Forward P/E 49.5x N/M
Trailing P/E 49.5x N/M
PEG Ratio N/M N/M
EV / Revenue 2.9x N/M
2. Growth & Scale GERN
Revenue Growth (YoY) +27.4% N/A
Earnings Growth (YoY) +0.0% N/A
TTM Revenue (USD) $218M N/A
Market Cap $588.2M N/A
3. Profitability & Quality GERN
Gross Margin 62.5% N/A
Operating Margin -7.2% N/A
Net Profit Margin -22.0% N/A
Return on Equity (ROE) -20.1% N/A
4. Balance Sheet & Cash Flow GERN
Cash Generation (TTM) -$91M N/A
Cash Flow Margin -41.9% N/A
Net Cash / Leverage $52M Net Debt (0.53x D/E) N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning ASTM
Options Structure Phase BREAKDOWN UNCLASSIFIED
Current IV / %ile 103.2% (19th %ile) N/A (N/A)
Put/Call OI Skew 0.15x (Call-Skewed) N/A
OBV Trend / Tech Phase DISTRIBUTION · Markdown NEUTRAL · Neutral
6. R&D & Supply-Chain Moat GERN
OpEx & R&D Intensity 69.7% of Rev ($152M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Biotechnology Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: GERN (7) vs ASTM (3)
Institutional Metric GERN ASTM Criterion Row Edge
Market Capitalization
Scale
$588.2M N/A Larger Scale GERN
Trailing P/E Ratio
Valuation
49.5x N/M Lower Multiple GERN
Forward P/E Ratio
Valuation
49.5x N/M Lower Multiple GERN
Revenue Growth (YoY)
Growth
+27.4% N/A Higher Growth GERN
Operating Margin (TTM)
Profitability
-7.2% N/A Higher Margin GERN
Net Profit Margin
Profitability
-22.0% N/A Higher Margin GERN
Return on Equity (ROE)
Capital Efficiency
-20.1% N/A Higher ROE GERN
52-Week Range Position
Momentum
3% ($1–$2) 53% ($25–$26) Stronger Trend ASTM
Beta / 30D Volatility
Risk Regime
1.48β · 102% Vol N/A Lower Realized Risk ASTM
Unified Institutional Score
Composite Signal
48.4 / 100 (HOLD) 50.6 / 100 (HOLD) Higher Composite ASTM
Trailing 12M Revenue (USD)
Operating Scale
$218M N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
62.5% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 2.9x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$91M ($52M Net Debt (0.53x D/E)) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon ASTM +23.47 pp
GERN: -22.95% · ASTM: +0.52%
3M Horizon ASTM +26.08 pp
GERN: -24.94% · ASTM: +1.14%
6M Horizon ASTM +26.08 pp
GERN: -24.94% · ASTM: +1.14%
1Y Horizon ASTM +26.08 pp
GERN: -24.94% · ASTM: +1.14%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GERN vs ASTM. Trailing 12-month operating profitability (GERN -7.2% vs ASTM N/A) and valuation multiples (GERN 49.5x vs ASTM N/M Forward P/E) are benchmarked directly in Pillar 4 below.

GERN ADR TTM Benchmark FX-Normalized USD
TTM Revenue$218M
Gross Margin62.5%
Op. Margin-7.2%
ROE / Fwd P/E-20.1% · 49.5x
ASTM ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
GERN BREAKDOWN
76d in phase · OBV DISTRIBUTION
Current IV 103.2%
IV Percentile 19th %ile
Put/Call OI Skew 0.15x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact GERN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ASTM UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ASTM Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
GERN Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $588.2M market capitalization and -7.2% operating margin.
OpEx & R&D Reinvestment 69.7% of Rev ($152M)
90D Engineering Disclosures 0 Published
ASTM Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ GERN vs ASTM Key Questions & Quantitative Answers

As of Nov 20, 2026, Geron Corp (GERN) is the stronger overall head-to-head candidate over ASTM (ASTM) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). GERN carries a Unified Composite Score of 48.4/100 (HOLD) at $0.87 (49.5x Forward P/E, -7.2% operating margin), whereas ASTM carries 50.6/100 (HOLD) at $25.29 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While ASTM currently prints a higher short-term Unified Composite Score (50.6/100 HOLD vs. GERN 48.4/100 HOLD), GERN captures the overall institutional head-to-head verdict (7–3 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (-7.2% vs. N/A operating margin) and revenue trajectory (+27.4% vs. N/A YoY). Technical & Structure Timing Caution: GERN is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 35.3); meanwhile ASTM trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI N/A). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

GERN leads the Growth & Scale pillar: GERN posts +27.4% YoY revenue growth and +0.0% YoY earnings growth on $218M TTM revenue (62.5% gross margin, -7.2% operating margin), compared with ASTM at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, GERN generates $218M in USD-normalized revenue versus N/A for ASTM. In operating R&D and SG&A reinvestment, GERN deploys 69.7% of Rev ($152M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for ASTM.

GERN screens cheaper on headline valuation multiples. GERN trades at 49.5x Forward P/E, 49.5x Trailing P/E, N/M PEG, and 2.9x EV/Revenue (-41.9% FCF margin), whereas ASTM trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against GERN (-20.1% ROE) versus ASTM (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, GERN carries 103.2% implied volatility (19th %ile, Compressed (<25th %ile)), a 0.15x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (1.48β · 102% Vol realized risk). By comparison, ASTM carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (N/A realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.